StonvexLoading…
StonvexStonvexStonvexCore line items from SPB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-29 | Q4 2025 2025-12-28 | Annual 2025 2025-09-30 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $741.51M | $1.39B | $677.00M | $2.81B | $2.08B |
Operating Income | Not available | $70.60M | $27.10M | $124.90M | $95.50M |
Net Income | Not available | $50.50M | $28.40M | $99.90M | $44.30M |
EPS (Diluted) | $1.48 | $2.16 | $1.21 | $3.86 | $1.68 |
Total Assets | Not available | $3.47B | $3.42B | $3.38B | $3.54B |
Total Liabilities | Not available | $1.57B | $1.52B | $1.47B | $1.65B |
Cash & Equivalents | Not available | $125.10M | $126.60M | $123.60M | $122.00M |
Free Cash Flow OCF − CapEx | Not available | $60.20M | $59.30M | $165.30M | $7.40M |
Shares Outstanding | Not available | 23.40M | 23.50M | 25.90M | 26.40M |